JURA Bio

Somerville, United States

Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders.

$16.1M raised

Sep 2023

Seed

Top Investors

John BallantyneFontus CapitalMichael ChambersJosh Ellington

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has JURA Bio raised?

JURA Bio has raised $16.1M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are JURA Bio's investors?

JURA Bio's investors include John Ballantyne, Fontus Capital, Michael Chambers, Josh Ellington.

Where is JURA Bio headquartered?

JURA Bio is headquartered in Somerville, United States.

What does JURA Bio do?

Jura Bio is a therapeutics company focused on translating successes in CAR-T to autoimmune disorders.

What stage is JURA Bio at?

JURA Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2023.

MLA

"JURA Bio — Funding & Investors." VCBacked, September 21, 2023, https://www.vcbacked.co/company/jura-bio. Accessed June 17, 2026.

APA

VCBacked. (2023). JURA Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/jura-bio

Wikipedia (cite web)

{{cite web |title=JURA Bio — Funding & Investors |url=https://www.vcbacked.co/company/jura-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2023.